Back to Rankings

CRSP

CRISPR TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CRSP vs peer average
56/100
CRSP vs. peer average (B vs. B)
Grade spread
A 2 · B 4 · C 2 · D 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

BEAM is the first available peer comparator.

Beam — base-editing specialist; contrasts on modality and commercialization path but similar event-driven volatility.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerBEAMBeam Therapeutics
CRSP
CRISPR Therapeutics
BEAM
Beam Therapeutics
Grade
B
B
Momentum
43
76
Value
41
41
Sentiment
89
66
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs BEAM

CRSP / BEAM
Grade Position
In line
CRSP vs. peer average (B vs. B)
56/100
Momentum
43
BEAM
Value
41
CRSP
Sentiment
89
CRSP

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CRSP
1
BEAM
BEAM
B
80/100
Even
2
EDIT
EDIT
B
80/100
Even
3
NTLA
NTLA
D
40/100
+2
4
XENE
Xenon Pharmaceuticals Inc Common
C
60/100
+1
5
STVN
Stevanato Group SpA Common
A
100/100
-1
BEAM is the first peer returned for this comparison set.